0001022079-24-000053.txt : 20240223 0001022079-24-000053.hdr.sgml : 20240223 20240223163502 ACCESSION NUMBER: 0001022079-24-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E CENTRAL INDEX KEY: 0001222679 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 24671878 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wk-form4_1708724091.xml FORM 4 X0508 4 2024-02-21 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001222679 PREVOZNIK MICHAEL E 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 SVP & General Counsel 1 Common Stock 2024-02-21 4 F 0 407 125.02 D 40867 D Common Stock 2024-02-22 4 S 0 661 126.14 D 40206 D Common Stock 5541 I 401(k)/SDCP Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik 2024-02-23